Journal
ENDOCRINOLOGY
Volume 150, Issue 3, Pages 1108-1111Publisher
ENDOCRINE SOC
DOI: 10.1210/en.2008-1596
Keywords
-
Categories
Funding
- National Institutes of Health [DK-52798]
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK052798, R01DK052798] Funding Source: NIH RePORTER
Ask authors/readers for more resources
3-Iodothyronamine (T(1)AM) is an endogenous compound with chemical features that are similar to thyroid hormone. T(1)AM has a carbon skeleton identical to that of T-4 and contains a single carbon-iodine bond. Theoretically, T(1)AM could be produced from T-4 by enzymatic decarboxylation and deiodination. Recent studies show that T(1)AM and higher iodinated thyronamines are subject to similar metabolic processing as iodothyronines such as T-4, suggesting a biological linkage between iodothyronines and iodothyronamines. In addition, single doses of T(1)AM administered to rodents induce a hypometabolic state that in certain ways resembles hibernation and is opposite to the effects of excess T-4. This review will discuss the latest developments on this recently discovered thyroid hormone derivative. (Endocrinology 150: 1108-1111, 2009)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available